Analystreport

Histogenics Corp (NASDAQ: HSGX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $3.50 price target on the stock.

HISTOGENICS CORP COMMON  (HSGX) 
Last histogenics corp common earnings: 8/9 04:11 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.histogenics.com